OKURA HOLDINGS(01655.HK)預計2020財年税前虧損不少於62.66億日圓
格隆匯 8 月 28日丨OKURA HOLDINGS(01655.HK)發佈公告,基於對截至2020年6月30日止年度管理賬目的初步審閲,集團預期錄得除所得税前虧損不少於62.66億日圓,而上年度則為除所得税前利潤約9.89億日圓。
誠如第一份盈利警告所強調,由於日本爆發新型冠狀病毒病後,日式彈珠機行業市況不利及集團日式彈珠機遊戲館前景不明朗,產生不少於62.55億日圓的該等減值虧損,該金額預期將於2020年6月30日確認,是為公司於2020年財年的盈利能力進一步惡化的主因。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.